Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
2(22%)
Results Posted
0%(0 trials)
Terminated
2(22%)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
8
89%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution9 total trials
Phase 3Large-scale testing
1(11.1%)
N/ANon-phased studies
8(88.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)
Other(3)

Detailed Status

unknown3
Terminated2
Recruiting2
Not yet recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
33.3%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (11.1%)
N/A8 (88.9%)

Trials by Status

terminated222%
recruiting222%
not_yet_recruiting111%
unknown333%
completed111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
9